Contact

Our portfolio

InSteps

Providing in-silico modeling for stroke treatment, InSteps develops a platform to simulate various stroke scenarios. Their technology aids in the development of thrombectomy devices and optimizes clinical trials, giving more patients access to life-saving treatments. The company is committed to enhancing stroke care through advanced simulation technology.

  • Institute: Amsterdam UMC
Industry: Neuroscience, Simulation, Stroke
  • Founding year: 2023
Visit website

Want to get in contact about InSteps?

We’re happy to connect. Reach out to our investment manager working with the team to learn more or explore potential opportunities.

Browse all investment managers

Marc Roelofs

Life Science & Health

Our portfolio

Check out similar ventures

AlpENa Biosciences
Developing bispecific antibodies as enhanced cancer immunotherapy.
Haermonics
Preventing post-surgical complications with the PURE pericardial flushing device.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Sightcorp
Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.
AlpENa Biosciences
Developing bispecific antibodies as enhanced cancer immunotherapy.
Haermonics
Preventing post-surgical complications with the PURE pericardial flushing device.
Scyfer
Developing advanced machine learning and deep learning technologies, Scyfer specializes in applying these solutions across various industries, including industry, media, and healthcare.
Sightcorp
Specializing in AI-powered audience intelligence, Sightcorp provides automated facial analysis and emotion recognition technology.
Explore full AAV portfolio
Contact